All In Biotech

Drug Trial Radar · NCT02187614

Efficacy Study of Different Analgesic Options in Kidney Stone Pain Management

A Double Blind, Multi-arm Randomized Control Trial, for Efficacy of Intramuscular Diclofenac Versus Intravenous Morphine Versus Intravenous Paracetamol, in Renal Colic Emergency Department Pain Management

Last checked: Nov 19, 2026Latest source record: Mar 18, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 1,645 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,645

Actual

Start

Aug 2014

Primary completion

Feb 2015

Study completion Mar 2015

Sponsor

Lead sponsor
Hamad Medical CorporationIndustry
Sponsor type
Industry
First posted
Jul 11, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Abdominal pain is one of the most common presentations to an emergency department (ED). Among patients presenting with abdominal pain, a common diagnosis in the Middle East is renal colic (urolithiasis or Kidney stones). As the patients with renal colic writhe around in agonizing pain, the first priority in an ED from a patient's perspective is fast and safe analgesia and to be pain free as early as possible. There are variations in physician preference to choose initial analgesic drug for managing such pain. Commonly used drugs are: * Opioids such as Morphine or Fentanyl * Non steroidal drugs such as Diclofenac, Ketorolac or Brufen * and Paracetamol intravenous injection. A robust evidence in comparison of diclofenac versus morphine and paracetamol is lacking. This study is design to obtain data on efficacy of these three drugs within 30 minutes in a non inferiority trail.

Conditions

  • Renal Colic
  • Urinary Calculi

Interventions

  • DiclofenacDrug

  • MorphineDrug

  • ParacetamolDrug

  • PlacebosDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The proportion of patients achieving a reduction of >50% on Numerical Rating Scale (NRS-11) from the initial NRS recorded at the end of 30 minutes in each study arm.Time frame: at 30 minutes after analgesia

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Emergency Department, Hamad General Hospital.

    Doha, Baladiyat ad Dawhah, Qatar

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.